Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001582342 | SCV001821211 | benign | not specified | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002070441 | SCV002377041 | likely benign | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260209 | SCV002539387 | benign | Familial visceral amyloidosis, Ostertag type | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260210 | SCV002539388 | benign | Hypoalphalipoproteinemia, primary, 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260211 | SCV002539389 | benign | Hypoalphalipoproteinemia, primary, 2, intermediate | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343769 | SCV002652036 | likely benign | Cardiovascular phenotype | 2022-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |